Movement Alert｜INSILICO Rises 5.5% in Regular Trading, First CVC Fund Launch Coupled with Upcoming Interim Results

Market Focus

Aug 25

On August 25, INSILICO rose 5.5% in regular trading, trading at HKD 42.68 per share, with turnover of approximately HKD 104 million.

On the news front, the company recently announced the establishment of its first CVC (Corporate Venture Capital) industrial fund in partnership with Value Partners Shenzhen and Pufa Group, targeting a total size of RMB 1.01 billion. The fund will focus on life sciences, covering areas such as company-incubated startups, life science models, and novel drug development. Yuanma Zhiyao is expected to be among the first key projects included in the fund.

Additionally, the company is scheduled to release its interim results on August 26. The market is closely watching the recognition of major BD milestone payments within the reporting period, including the USD 115 million upfront payment from the Eli Lilly collaboration and approximately USD 60 million in initiation fees from Takeda. Earlier in July, INSILICO also announced strategic partnerships with Tencent Health and signed a tripartite cooperation agreement with Yuanma Zhiyao and Shaqiu Quantum during WAIC.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1164319418"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164319418\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164319418?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-25 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164319418","market":"hk","top_or_hot":-1,"title":"Movement Alert｜INSILICO Rises 5.5% in Regular Trading, First CVC Fund Launch Coupled with Upcoming Interim Results","media":"Market Focus","content":"<p><p>On August 25, INSILICO rose 5.5% in regular trading, trading at HKD 42.68 per share, with turnover of approximately HKD 104 million.</p><p>On the news front, the company recently announced the establishment of its first CVC (Corporate Venture Capital) industrial fund in partnership with Value Partners Shenzhen and Pufa Group, targeting a total size of RMB 1.01 billion. The fund will focus on life sciences, covering areas such as company-incubated startups, life science models, and novel drug development. Yuanma Zhiyao is expected to be among the first key projects included in the fund.</p><p>Additionally, the company is scheduled to release its interim results on August 26. The market is closely watching the recognition of major BD milestone payments within the reporting period, including the USD 115 million upfront payment from the Eli Lilly collaboration and approximately USD 60 million in initiation fees from Takeda. Earlier in July, INSILICO also announced strategic partnerships with Tencent Health and signed a tripartite cooperation agreement with Yuanma Zhiyao and Shaqiu Quantum during WAIC.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INSILICO Rises 5.5% in Regular Trading, First CVC Fund Launch Coupled with Upcoming Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INSILICO Rises 5.5% in Regular Trading, First CVC Fund Launch Coupled with Upcoming Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-25 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 25, INSILICO rose 5.5% in regular trading, trading at HKD 42.68 per share, with turnover of approximately HKD 104 million.</p><p>On the news front, the company recently announced the establishment of its first CVC (Corporate Venture Capital) industrial fund in partnership with Value Partners Shenzhen and Pufa Group, targeting a total size of RMB 1.01 billion. The fund will focus on life sciences, covering areas such as company-incubated startups, life science models, and novel drug development. Yuanma Zhiyao is expected to be among the first key projects included in the fund.</p><p>Additionally, the company is scheduled to release its interim results on August 26. The market is closely watching the recognition of major BD milestone payments within the reporting period, including the USD 115 million upfront payment from the Eli Lilly collaboration and approximately USD 60 million in initiation fees from Takeda. Earlier in July, INSILICO also announced strategic partnerships with Tencent Health and signed a tripartite cooperation agreement with Yuanma Zhiyao and Shaqiu Quantum during WAIC.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1164319418","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164319418","pubTimestamp":1787621979,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 25, INSILICO rose 5.5% in regular trading, trading at HKD 42.68 per share, with turnover of approximately HKD 104 million.On the news front, the company recently announced the establishment...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"走势警报|INSILICO 在常规交易中上涨 5.5%，首只 CVC 基金推出，加上即将公布的中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On August 25, INSILICO rose 5.5% in regular trading, trading at HKD 42.68 per share, with turnover of approximately HKD 104 million.On the news front, the company recently announced the establishment of its first CVC (Corporate Venture Capital) industrial fund in partnership with Value Partners Shenzhen and Pufa Group, targeting a total size of RMB 1.01 billion. The fund will focus on life sciences, covering areas such as company-incubated startups, life science models, and novel drug development. Yuanma Zhiyao is expected to be among the first key projects included in the fund.Additionally, the company is scheduled to release its interim results on August 26. The market is closely watching the recognition of major BD milestone payments within the reporting period, including the USD 115 million upfront payment from the Eli Lilly collaboration and approximately USD 60 million in initiation fees from Takeda. Earlier in July, INSILICO also announced strategic partnerships with Tencent Health and signed a tripartite cooperation agreement with Yuanma Zhiyao and Shaqiu Quantum during WAIC.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}